Endologix Announces First Patient Treated in Ventana(TM) U.S. Clinical Trial

Posted on : 01 June 2014
 Read more

MHRA issues statement on metal-on-metal hip implants

Posted on : 30 January 2012
The MHRA have issued a statement on DePuy's metal-on-metal hip implants, while the Telegraph newspaper reports concerns that the devices could be more dangerous than previously thought... Read more

Medtronic completes enrollment of extreme risk patient group in CoreValve trial

Posted on : 25 January 2012
Medtronic has announced the completion of the company's patient enrollment in the extreme risk study in its CoreValve U.S. Trial... Read more

Which Medical Device launches new anaesthetics device section

Posted on : 23 January 2012
Which Medical Device is delighted to launch a new section dedicated to anaesthetics devices... Read more

DePuy suspends distribution of custom devices following FDA warning

Posted on : 23 January 2012
Johnson & Johnson subsidiary Depuy Orthopaedics has decided to stop selling all custom devices following an FDA letter warning... Read more

Rise in knee replacements among 30 to 59 year-olds

Posted on : 20 January 2012
A study reports a rise in the incidence of knee arthroplasty for primary osteoarthritis among baby-boomers in Finland... Read more

Gore receives FDA approval for TAG Thoracic Endoprosthesis

Posted on : 19 January 2012
The FDA has approved the GORE TAG Thoracic Endoprosthesis for endovascular repair of the descending thoracic aorta... Read more

Device of the Year 2011 Winners Announced!

Posted on : 16 January 2012
Which Medical Device are delighted to announce the winners of the Device of the Year Awards 2011... Read more

JACC study suggests increase in CeV events after TAVI

Posted on : 10 January 2012
A JACC study has found an increase in CeV events for two months after TAVI...  Read more

Research shows lower adverse-events for drug-eluting stents than bare metal stents in patients over 85

Posted on : 04 January 2012
A report published in the Journal of the American College of Cardiology has observed lower adverse-event rates associated with DES versus BMS use.  Read more

Study suggests RFA could be first-line treatment for early-stage HCC patients

Posted on : 03 January 2012
A study published in The American Journal of Gastroenterology suggests RFA might be a first-line treatment for selected patients with early-stage Hepatocellular Carcinoma. Read more

WhichMedicalDevice is a FREE resource created by clinicians for clinicians.

Registration is free and gives you unlimited access to all of the content and features of this website.

Find out more...

Please sign in to view this content...

I have forgotten my password
Not a Member?

Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...

Why Register

Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.

We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.